Covered recipient · General Payments record
THOMAS T SANDS
Allopathic & Osteopathic Physicians Plastic Surgery
General Payments · PY2018–2024
$11,086.80
- Reported across 249 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,155.57 | 41 |
| Long term medical supply or device loan | $325.80 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $855.48 | 29 |
| Integra LifeSciences Corporation | $325.80 | 1 |
| REVANCE THERAPEUTICS, INC. | $172.72 | 6 |
| MOTIVA USA, LLC | $53.51 | 2 |
| Galderma Laboratories, L.P. | $38.57 | 2 |
| Pacira Pharmaceuticals Incorporated | $21.00 | 1 |
| Lilly USA, LLC | $14.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (42)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.39 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015715 | CMS |
| ABBVIE INC. | $23.92 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015717 | CMS |
| ABBVIE INC. | $3.62 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015719 | CMS |
| ABBVIE INC. | $21.33 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015721 | CMS |
| ABBVIE INC. | $26.33 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015723 | CMS |
| ABBVIE INC. | $22.48 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015725 | CMS |
| ABBVIE INC. | $21.23 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015727 | CMS |
| ABBVIE INC. | $13.86 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015729 | CMS |
| ABBVIE INC. | $13.85 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015731 | CMS |
| ABBVIE INC. | $15.18 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015733 | CMS |
| ABBVIE INC. | $23.25 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015735 | CMS |
| ABBVIE INC. | $8.32 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015737 | CMS |
| ABBVIE INC. | $23.56 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015739 | CMS |
| ABBVIE INC. | $20.99 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015741 | CMS |
| ABBVIE INC. | $23.43 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015743 | CMS |
| ABBVIE INC. | $47.59 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015745 | CMS |
| ABBVIE INC. | $15.85 | 07/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015747 | CMS |
| ABBVIE INC. | $122.87 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015749 | CMS |
| ABBVIE INC. | $83.55 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015751 | CMS |
| ABBVIE INC. | $14.44 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015753 | CMS |
| ABBVIE INC. | $16.27 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015755 | CMS |
| ABBVIE INC. | $24.01 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015757 | CMS |
| ABBVIE INC. | $16.51 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015759 | CMS |
| ABBVIE INC. | $25.65 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015761 | CMS |
| ABBVIE INC. | $24.18 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015763 | CMS |
| ABBVIE INC. | $21.89 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015765 | CMS |
| ABBVIE INC. | $5.72 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015767 | CMS |
| ABBVIE INC. | $18.43 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015769 | CMS |
| ABBVIE INC. | $143.78 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106015771 | CMS |
| Galderma Laboratories, L.P. | $22.77 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145326101 | CMS |
| Galderma Laboratories, L.P. | $15.80 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145326103 | CMS |
| Integra LifeSciences Corporation | $325.80 | 10/10/2024 | Long term medical supply or device loan | Undisputed | 01/23/2026 | 1140137703 | CMS |
| Lilly USA, LLC | $14.29 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135464414 | CMS |
| MOTIVA USA, LLC | $31.51 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139155174 | CMS |
| MOTIVA USA, LLC | $22.00 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139155160 | CMS |
| Pacira Pharmaceuticals Incorporated | $21.00 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151260152 | CMS |
| REVANCE THERAPEUTICS, INC. | $31.26 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147928421 | CMS |
| REVANCE THERAPEUTICS, INC. | $30.65 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147928423 | CMS |
| REVANCE THERAPEUTICS, INC. | $17.79 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147928425 | CMS |
| REVANCE THERAPEUTICS, INC. | $17.27 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147928427 | CMS |
| REVANCE THERAPEUTICS, INC. | $28.27 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147928429 | CMS |
| REVANCE THERAPEUTICS, INC. | $47.48 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147928431 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.